Aflac Incorporated (NYSE:AFL) Receives $103.93 Consensus Target Price from Brokerages

Shares of Aflac Incorporated (NYSE:AFL - Get Free Report) have received a consensus rating of "Hold" from the fourteen ratings firms that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, ten have given a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $103.93.

A number of brokerages recently commented on AFL. Morgan Stanley dropped their price target on Aflac from $105.00 to $100.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. StockNews.com upgraded shares of Aflac from a "sell" rating to a "hold" rating in a report on Friday, February 14th. UBS Group increased their target price on shares of Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a research report on Wednesday, April 2nd. Piper Sandler lifted their price target on shares of Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Finally, Keefe, Bruyette & Woods lowered their target price on Aflac from $107.00 to $104.00 and set a "market perform" rating on the stock in a research note on Wednesday, February 12th.

Remove Ads

Insiders Place Their Bets

In other Aflac news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now directly owns 49,962 shares of the company's stock, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now directly owns 25,393 shares of the company's stock, valued at $2,733,048.59. This represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.90% of the company's stock.

Institutional Trading of Aflac

A number of hedge funds and other institutional investors have recently modified their holdings of AFL. Whipplewood Advisors LLC bought a new stake in Aflac during the fourth quarter worth about $26,000. BankPlus Trust Department bought a new stake in shares of Aflac in the 4th quarter worth approximately $34,000. Curio Wealth LLC purchased a new stake in shares of Aflac in the 4th quarter worth approximately $36,000. OFI Invest Asset Management bought a new position in Aflac during the 4th quarter valued at approximately $38,000. Finally, Capital A Wealth Management LLC purchased a new position in Aflac during the fourth quarter valued at $38,000. 67.44% of the stock is owned by hedge funds and other institutional investors.

Aflac Stock Up 0.1 %

NYSE AFL traded up $0.14 on Friday, hitting $108.65. 440,901 shares of the company were exchanged, compared to its average volume of 2,007,472. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The company has a market cap of $59.30 billion, a PE ratio of 11.32, a PEG ratio of 3.24 and a beta of 0.81. The stock has a fifty day moving average of $106.37 and a 200-day moving average of $107.39. Aflac has a 12 month low of $79.69 and a 12 month high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, analysts forecast that Aflac will post 6.88 earnings per share for the current year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.